Product information

Montelukast KRKA 4 mg
28
montelukast
3155389
2.27 / 10
Locked

Product properties

158966-92-8
R03DC03
KRKA d.d. Novo mesto
Chewable tablet
€9.61
BE379662
03838989692353
M1
Public
379662-05

Pharmacist Assessment

Discontinued product — remaining stock available

The commercialization of this product has been stopped (reason: Insufficient demand), but remaining stock is available at wholesalers (score 2.27/10). This stock will not be replenished. Plan the switch to an alternative.

Recommended alternative

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 7 of 18 warehouse locations have stock
  • 2 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Active
- present

Insufficient demand

Alternative available
Available
Until 29/06/2026

Composition

3 ingredients

Substance Type Strength CAS
Active ingredient
4.16 mg
151767-02-1
Excipient
168.84 mg
Excipient
1.2 mg

Additional information

View on BCPI

Availability statistics

Commercialization stopped
35 days
4
0
30/06/2026